Journal Article Summary
The article investigates the prevalence of regular aspirin use among adults with existing atherosclerotic cardiovascular disease (ASCVD) in 20 states and the District of Columbia. This topic is significant because aspirin therapy is well-established as an effective method for reducing the risk of heart attacks and strokes in individuals who already have cardiovascular disease. Understanding how widely aspirin is used in this population can help identify gaps in treatment and inform public health strategies aimed at improving cardiovascular health.
To conduct the study, researchers analyzed data from the 2013 Behavioral Risk Factor Surveillance System (BRFSS), which included responses from over 175,000 adults. Among those with a history of ASCVD, 70.8% reported using aspirin regularly, with the majority taking it to prevent heart attacks (93.6%) and strokes (79.6%). The study also found variations in aspirin use based on factors such as age, sex, race/ethnicity, and the number of ASCVD risk factors, indicating that certain groups may be less likely to use aspirin for prevention.
The article acknowledges several limitations, including the lack of data on other antiplatelet medications and the reliance on self-reported information, which can lead to inaccuracies. Additionally, the study did not differentiate between types of strokes, which may affect aspirin use recommendations. Readers are encouraged to discuss aspirin use with their healthcare providers, particularly if they have existing cardiovascular conditions, to ensure they receive appropriate guidance tailored to their individual health needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Fang Jing, George Mary G., Hong Yuling, Loustalot Fleetwood. Use of Aspirin for Prevention of Recurrent Atherosclerotic Cardiovascular Disease Among Adults — 20 States and the District of Columbia, 2013. Morbidity and Mortality Weekly Report 2015. PMID: 26182190. PMCID: PMC4584583.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
